Discovery of a chalcone derivative as an anti-fibrotic agent targeting transforming growth factor-β1 signaling: Potential therapy of renal fibrosis
Open Access
- 10 July 2023
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 165, 115098
Abstract
No abstract availableKeywords
Funding Information
- Mahidol University
This publication has 39 references indexed in Scilit:
- Melittin Inhibits TGF-β-Induced Pro-Fibrotic Gene Expression Through the Suppression of the TGFβRII-Smad, ERK1/2 and JNK-Mediated Signaling PathwayThe American Journal of Chinese Medicine, 2014
- Inhibitory effects of rapamycin on the different stages of hepatic fibrosisWorld Journal of Gastroenterology, 2014
- Transforming growth factor- and the progression of renal diseaseNephrology Dialysis Transplantation, 2013
- Transforming Growth Factor-β, Bioenergetics, and Mitochondria in Renal DiseaseSeminars in Nephrology, 2012
- Tuberin Regulates E-Cadherin LocalizationThe American Journal of Pathology, 2010
- Renal fibrosis: novel insights into mechanisms and therapeutic targetsNature Reviews Nephrology, 2010
- Obstructive UropathyClinics in Geriatric Medicine, 2009
- Alanine aminotransferase isoenzymes: Molecular cloning and quantitative analysis of tissue expression in rats and serum elevation in liver toxicity #Hepatology, 2009
- In vitro models of TGF-β-induced fibrosis suitable for high-throughput screening of antifibrotic agentsAmerican Journal of Physiology-Renal Physiology, 2007
- Rapamycin Markedly Slows Disease Progression in a Rat Model of Polycystic Kidney DiseaseJournal of the American Society of Nephrology, 2005